News & Updates
Filter by Specialty:
Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life
Among patients with epilepsy, quality of life (QOL) declines with antiseizure medication (ASM) polytherapy, and this effect is mediated by depression and the side effects of ASMs, as reported in a study.
Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life
17 Jan 2022
Study throws light on vaccine hesitancy in Singapore
COVID-19 vaccine acceptance is high in Singapore, but there are still a reluctant few who prevent the nation from getting a higher immunization coverage against the infection.
Study throws light on vaccine hesitancy in Singapore
15 Jan 2022
Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL
The combination of polatuzumab vedotin with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) demonstrated a significant improvement in progression-free survival (PFS) over the standard-of-care (SoC) regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL), according to results of the phase III POLARIX study.
Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL
14 Jan 2022
Fenofibrate keeps lid on triglyceride in NASH patients receiving ACC inhibitor
For nonalcoholic steatohepatitis (NASH) patients with hypertriglyceridaemia, treatment with fenofibrate helps reduce the increases in triglyceride levels associated with acetyl-coenzyme A carboxylase (ACC) inhibition, as shown in a study.